Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Evaluation of two clinical Centiloid analysis products for (18)F-florbetapir PET in cognitively unimpaired elders.

Cerebrospinal fluid YKL-40 relates to white matter hyperintensity progression in females but not males over a 6-year period.

脑脊液 YKL-40 与女性（而非男性）6 年内的白质高信号进展有关

Rest-activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women.

与中年女性认知能力下降和阿尔茨海默病生物标志物相关的休息-活动节律特征

Clinical decision points for two plasma p-tau217 laboratory developed tests in neuropathology confirmed samples.

针对神经病理学确诊样本，制定了两种血浆 p-tau217 实验室检测方法的临床决策点

Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline.

神经炎症潜在因素与阿尔茨海默病病理及纵向认知衰退的关联

Assessing Alzheimer's disease via plasma extracellular vesicle-derived mRNA

通过血浆细胞外囊泡衍生的 mRNA 评估阿尔茨海默病

Omega-3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia

Omega-3 血液生物标志物与阿尔茨海默病痴呆风险个体的大脑葡萄糖摄取有关

Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology

Aβ 寡聚体在阿尔茨海默病的早期阶段达到峰值，早于 tau 病理

Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study

使用无抗体 LC-MS 方法检测 A4 研究筛查访视中认知未受损个体的脑淀粉样蛋白沉积的临床应用

Relationship between baseline plasma p-tau181 and longitudinal changes in cognition and structural brain measures in a cohort of cognitively unimpaired older adults

认知未受损的老年人群中血浆基线 p-tau181 与认知和脑结构测量纵向变化之间的关系